ioneer (US:IONR)2026-03-18 12:56Financial Performance - The Group reported a net loss after tax of $4,070,000 for the six months ended 31 December 2025, a 57% improvement compared to the loss of $9,554,000 for the year ended 30 June 2025[32]. - Operating cash flows improved by 55%, from a negative $6,805,000 for the year ended 30 June 2025 to a negative $3,069,000 for the six months ended 31 December 2025[34]. - Revenue for the six months ended December 31, 2025, was $328,000, a decrease from $653,000 for the previous twelve months[181]. - Loss before income tax expense for the six months was $4,070,000, compared to a loss of $9,554,000 for the previous twelve months[181]. - Total comprehensive income for the period attributable to the owners was a loss of $3,863,000, compared to a loss of $9,823,000 for the previous twelve months[181]. - Cash and cash equivalents decreased to $17,863,000 from $25,059,000 at the end of the previous period[182]. - Total assets slightly decreased to $232,543,000 from $233,541,000[182]. - Total liabilities decreased to $2,324,000 from $3,243,000, indicating improved financial stability[182]. - Net cash used in operating activities for the six months was $3,069,000, compared to $6,805,000 for the previous twelve months[184]. - Expenditure on exploration and evaluation was $6,629,000 for the six months, down from $14,510,000 for the previous twelve months[184]. - Issued capital increased to $309,498,000 from $302,651,000, reflecting ongoing capital raising efforts[183]. Project Development - Ioneer closed a $996 million loan from the U.S. Department of Energy's Office of Energy Dominance Financing in January 2025 to support the development of the Rhyolite Ridge project[6]. - The project economics improved significantly, with a 64% increase in unlevered NPV to $2.23 billion and an 18.0% unlevered IRR, following a reduction in leach duration from 3 days to 1.5 days[8]. - The estimated all-in sustaining cash cost to produce battery-grade lithium hydroxide is US$4,628 per tonne, positioning Rhyolite Ridge in the lowest cost quartile for lithium production globally[13]. - The strategic partnering process is ongoing, with active discussions to identify strong equity partners for Rhyolite Ridge, expected to conclude in the first half of 2026[4]. - The U.S. Department of Interior added boron to its Final 2025 List of Critical Minerals, enhancing the strategic importance of Rhyolite Ridge[17]. - The current mine plan consists entirely of Reserve material, with approximately 35% classified as Proved Ore Reserve, allowing for potential mine life extension[15]. - Ioneer is developing a commercial-scale refining plant for lithium clay in partnership with EcoPro Innovation, with a commercially feasible process flow sheet completed[21]. - The independent evaluation of the Rhyolite Ridge cost estimate confirmed the quality of the project’s cost estimate and risk management framework[23]. - Ioneer holds all significant Federal and State authorizations required for the construction of Rhyolite Ridge, with ongoing legal proceedings related to environmental approvals[24]. - The company is focused on developing the Rhyolite Ridge Lithium-Boron Project, which is the only permitted, shovel-ready lithium-boron project in the U.S.[36]. - The company has secured a $996 million loan from the U.S. Department of Energy to support the development of an on-site processing facility at the Project[42]. - The company has completed 70% of the detailed engineering design, positioning it to be construction-ready at the Final Investment Decision (FID)[37]. - The company anticipates concluding its Strategic Partnering process in the first half of 2026, which is crucial for project financing and execution[36]. - The company plans to issue a 2026 Sustainability Report in the first half of 2027[64]. Shareholder and Executive Compensation - Ioneer Limited's directors hold a total of 150,648,853 shares and 24,357,658 performance rights as of December 31, 2025[50]. - James D Calaway, the Executive Chair, holds 63,595,869 shares and 7,206,821 performance rights[50]. - Bernard Rowe, a director, holds 78,806,195 shares and 16,198,505 performance rights[50]. - Timothy Woodall, an independent non-executive director, holds 375,000 shares and 388,083 performance rights[50]. - Ian Bucknell resigned as Chief Financial Officer and Company Secretary effective December 4, 2025[49]. - April Hashimoto will assume the role of Chief Financial Officer effective December 4, 2025[49]. - The company has a strong leadership team with extensive experience in finance, engineering, and resource sectors[49]. - The board includes members with significant backgrounds in M&A, finance, and project management[49]. - The company is committed to expanding its market presence and enhancing its operational capabilities through strategic leadership[49]. - The company issued 400,000,000 new fully paid ordinary shares at an issue price of A$0.18 (~US$0.13) per share, raising gross proceeds of A$72 million (~US$50 million) to accelerate the development of Rhyolite Ridge[71]. - The company has experienced low turnover at the executive KMP and senior management levels, with an annual retention rate well above 90% despite challenges in the lithium sector over the last three years[88]. - No changes were made to board fees, which have remained unchanged since 2020[89]. - At the October 2025 Annual General Meeting, 72.7% of shareholders voted for the FY2025 remuneration report, falling 2.3% short of the 75% threshold for avoiding a first strike[90]. - The company plans to continue engaging with shareholders and proxy advisers for feedback, believing that executive KMP remuneration is conservatively configured to meet market standards while conserving cash[92]. - The Board decided to discontinue the practice of allowing employees, including executive KMPs, to receive a 20% uplift in STI payments by deferring payment and converting cash to equity[94]. - The maximum total remuneration quantum for FY2025 was deemed appropriate, as the company must pay North American rates to attract and retain US-based executives[106]. - The company’s compensation framework aligns with U.S. standards, typically involving less cash and more equity compared to Australian market standards[108]. - The performance objectives for STI and equity vesting are designed to accelerate development during the pre-production phase, aligning with shareholder value[108]. - The company has not made any one-off equity grants in FY2025[94]. - The LTIP plan includes a time-based element, with only 25% of the LTIP subject to service, which is less than the market practice for most executive KMPs[91]. - Executive KMP annual base salaries were not increased during TY2025, with the base salary for James D Calaway at A$250,000 and Bernard Rowe at A$585,000[116]. - The maximum short-term incentive (STI) opportunity for the Managing Director is 160%, with a prorated amount of 80% for TY2025[120]. - The STI scorecard for TY2025 includes a target of 40% for strategic partnering, with a stretch goal of announcing deals to the market[123]. - Performance-based PRs comprise 60% of the annual target grant value, with a maximum of 75% based on performance metrics[116]. - The long-term incentive (LTI) performance period for TY2025 is adjusted to 42 months, covering from July 1, 2025, to December 31, 2028[124]. - The STI scorecard includes a financial target of spending levels at or below budget, with a base requirement of spending within 1% of the approved budget[123]. - The Board reserves the right to grant above 200% of target STI for exceptional contributions or exercise negative discretion based on shareholder experience[121]. - Time-based PRs make up 40% of the annual target grant value, contingent upon the employee remaining employed until the vesting date[116]. - The Company benchmarks executive KMP base salaries against resource industry market surveys, aiming to position at the P25-P50 level of the market[115]. - The maximum STI opportunity for the Senior Vice President Engineering & Operations is 100%, with a prorated amount of 50% for TY2025[120]. - The company reported a net loss after tax of US$4,070,000 for the six months ended December 31, 2025, compared to a loss of US$9,553,000 for the previous six months[138]. - Basic loss per share was US(0.169) for the six months ended December 31, 2025, compared to US(0.405) for the previous period[138]. - The closing share price increased to A$0.19 as of December 31, 2025, up from A$0.10 six months prior[138]. - The company aims to increase the Measured and Indicated LCE Resource by 10% by June 30, 2025, as part of its long-term strategy[132]. - The maximum incentive opportunity for the Managing Director is set at 48% of base salary for TY2025, reflecting a longer service period[136]. - The vesting scale for shareholder return components indicates that achieving the bottom quartile results in 0% vesting, while the first quartile results in 200% vesting[131]. - The company has set performance targets that include advancing project funding and enhancing project economics through plant optimization for TY2025[141]. - The Board has established a minimum share ownership requirement of five times base salary for the Managing Director over a five-year period[137]. - The company’s total shareholder return over five years was reported at (33.93%) as of December 31, 2025[138]. - The performance rights (PRs) issued are subject to vesting conditions and may be adjusted pro-rata in case of capital restructuring[128]. - The company achieved a 6% reduction in spending compared to the approved budget, demonstrating fiscal discipline[143]. - The strategic partnering process remains active but was delayed from the original schedule, resulting in a 0% outcome for the strategic partnering measure[145]. - The unlevered Project NPV improved by 38% and 64% due to enhanced mining and process plant optimization, exceeding expectations[143]. - There were no OSHA recordable workplace injuries during the performance period, achieving excellent safety outcomes[143]. - The company obtained modified State Air/Water permits and made significant progress in transferring operational water rights, with beneficial agreements reached[143]. - Employee retention was maintained with only one key staff departure during the period, achieving a 5% outcome for this measure[145]. - The total STI payout for executives was calculated at 70% of target, reflecting mixed performance across various measures[144]. - The company spent 6% below budget, with close attention to funding constraints taken into account[143]. - The anticipated first transplanting and seeding of Tiehm's Buckwheat is expected in March, although delays were caused by the U.S. Government shutdown[143]. - The company reviewed over 40 sites for outplanting suitability, selecting two 40-acre sites for trials[143]. - Total equity vesting for executives amounted to 182,561,362 shares, with a net change of 3,781,102 shares during the period[158]. - James D. Calaway holds 63,595,869 shares after acquiring 4,600,759 shares, while Bernard Rowe has 78,806,195 shares after acquiring 9,197,048 shares[158]. - Ian Bucknell's balance increased to 8,945,076 shares after acquiring 3,144,310 shares, despite a disposal of 500,000 shares[158]. - The total balance of ordinary shares for non-executive directors reached 5,914,149 shares, reflecting an increase of 887,890 shares[158]. - The company reported that all remaining options have lapsed, indicating no outstanding options as of the reporting date[160]. - The fair value of options granted to executives was set at 0.138, with an exercise price of 0.185[161]. - The total number of performance rights granted, vested, or lapsed during the year 2025 is detailed in the remuneration report[162]. - The company appointed April Hashimoto as Interim Chief Financial Officer effective November 6, 2025[159]. - The net change in performance rights for executives was recorded as 652,646 shares, all of which lapsed[161]. - The total balance of shares for executive directors reached 159,113,089 shares, with a net change of 27,106,663 shares[158]. - The total fair value of granted rights for 2025 STI and LTI is approximately $41.54 million, with $25.65 million lapsed and $12.11 million performance-based rights lapsed[164]. - 100% of the 2022 LTI time-based rights have lapsed for several executives, indicating a complete vesting failure for this period[164]. - The performance-based rights for 2022 LTI show an 18% vesting rate, with significant lapses totaling approximately $688,902 across various executives[164]. - The 2025 STI time-based rights granted to executives include a one-off ROD bonus with a vesting period of one day, contingent on achieving a positive Record of Decision in FY2025[164]. - The total number of rights granted for 2025 LTI performance-based is 5,836,000, with no rights vested yet[164]. - The company has a significant number of lapsed rights, with a total of 25,650,020 lapsed rights reported for the current period[164]. - The 2024 STI time-based rights have a 100% lapse rate for multiple executives, indicating a potential issue with performance targets[164]. - The company has implemented a new strategy for executive compensation, focusing on performance-based incentives to align with long-term goals[167]. - The total fair value of rights granted for 2025 STI is approximately $6.2 million, with 100% of certain rights vested[164]. - The company is facing challenges in retaining executive talent, as indicated by the resignation of key executives without pro-rata incentives being paid[165]. - The Executive Chair's base salary is set at US$250,000 per annum, effective January 4, 2025, in addition to the existing non-executive chair remuneration of US$185,000[170]. - The Managing Director's base salary is A$585,000 per annum, with a target bonus of 80% of base salary and a maximum STI of 200% of target (160% of base salary)[171]. - The Executive Chair is eligible for a target bonus of 60% of base salary, with a maximum STI of 200% of target (120% of base salary)[170]. - Performance-based awards for the Executive Chair may range from 0 to 200% of grant based on achievement of pre-established targets, with a maximum performance-based PRs of 72% of base salary[171]. - Non-executive Directors' remuneration is capped at A$1,000,000 per annum, including superannuation and retirement benefits[174]. - The Senior Vice President of Engineering & Operations is eligible for a target bonus of 50% of base salary, with a maximum STI of 200% of target (100% of base salary)[172]. - The Vice President of Human Resources is eligible for a target bonus of 40% of base salary, with a maximum STI of 200% of target (80% of base salary)[172]. - The equity grant for the Managing Director is set at 120% of base salary, with 60% performance-based and 40% time-based[171]. - The total fees for Non-executive Directors include cash and equity components, with the Chair receiving A$150,000 in cash and A$35,000 in equity[177]. - Hedging of Performance Rights by Non-executive Directors is not permitted[180].